QUICKly Eradicate Hepatitis C in Patients Undergoing REnal Transplant With 4 Weeks of Glecaprevir/Pibrentasvir
Clinical trial NCT04515797 · TERMINATED
Trial details
- NCT number
- NCT04515797
- Sponsor
- Massachusetts General Hospital
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-01
- Primary completion
- 2023-08-31
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.